Connecting linkedin

W1siziisijiwmtqvmtavmjgvmtuvndivmjavotqvzmlszsjdlfsiccisinrodw1iiiwimjawmhg3mdbcdtawm2mixv0

Is This The Next Billion-Dollar Biotech Idea?

12/05/2014 by

W1siziisijiwmtqvmtavmjgvmtuvndivmjavotqvzmlszsjdlfsiccisinrodw1iiiwinjawedqwmfx1mdazzsjdxq

Developing a new drug costs hundreds of millions of dollars, but for every five drugs that reach the market, another 95 end up in the trash bin.

That makes finding the next big thing in biotech particularly hit or miss. Frankly, the odds are stacked against biotech investors, because the odds are stacked against the biotech industry.

Small biotech companies generally have just one or two compelling ideas under development, which means that if one fails, the stock will take a substantial hit. That doesn’t mean, however, that investors can’t benefit from billion-dollar biotech blockbusters; it simply means they may want to develop a better strategy.

Rather than focusing on fly by night, unproven therapies, investors may want to look for opportunities to capture the billions of dollars in sales that are already being generated by the largest drug makers in the world.

That leads me to what I believe may be one of the biggest coming long-term trends in biotech: biosimilars. These are generic, copycat versions of biologic drugs such as AbbV blockbuster autoimmune drug Humira.

This article has been extracted from http://www.fool.com, please click on this link to read the article in full http://www.fool.com/investing/general/2014/05/11/is-this-the-next-billion-dollar-biotech-idea.aspx

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

For more information please visit www.montash.com

Our

Latest Blogs